Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 105

    1.

    Glucose metabolism in vivo in four commonly used inbred mouse strains.

    Berglund ED, Li CY, Poffenberger G, Ayala JE, Fueger PT, Willis SE, Jewell MM, Powers AC, Wasserman DH.

    Diabetes. 2008 Jul;57(7):1790-9. Epub 2008 Apr 8.PMID: 18398139 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Glucose homeostasis and tissue transcript content of insulin signaling intermediates in four inbred strains of mice: C57BL/6, C57BLKS/6, DBA/2, and 129X1.

    Goren HJ, Kulkarni RN, Kahn CR.

    Endocrinology. 2004 Jul;145(7):3307-23. Epub 2004 Mar 24.PMID: 15044376 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Differential effect of inbred mouse strain (C57BL/6, DBA/2, 129T2) on insulin secretory function in response to a high fat diet.

    Andrikopoulos S, Massa CM, Aston-Mourney K, Funkat A, Fam BC, Hull RL, Kahn SE, Proietto J.

    J Endocrinol. 2005 Oct;187(1):45-53.PMID: 16214940 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Carcinoembryonic antigen-related cell adhesion molecule 1: a link between insulin and lipid metabolism.

    DeAngelis AM, Heinrich G, Dai T, Bowman TA, Patel PR, Lee SJ, Hong EG, Jung DY, Assmann A, Kulkarni RN, Kim JK, Najjar SM.

    Diabetes. 2008 Sep;57(9):2296-303. Epub 2008 Jun 10.PMID: 18544705 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.
    8.

    Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse.

    Ayala JE, Bracy DP, McGuinness OP, Wasserman DH.

    Diabetes. 2006 Feb;55(2):390-7.PMID: 16443772 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Comparison of insulin secretory function in two mouse models with different susceptibility to beta-cell failure.

    Kooptiwut S, Zraika S, Thorburn AW, Dunlop ME, Darwiche R, Kay TW, Proietto J, Andrikopoulos S.

    Endocrinology. 2002 Jun;143(6):2085-92.PMID: 12021173 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Phosphorylation barriers to skeletal and cardiac muscle glucose uptakes in high-fat fed mice: studies in mice with a 50% reduction of hexokinase II.

    Fueger PT, Lee-Young RS, Shearer J, Bracy DP, Heikkinen S, Laakso M, Rottman JN, Wasserman DH.

    Diabetes. 2007 Oct;56(10):2476-84. Epub 2007 Jul 16.PMID: 17639019 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Regulation of glucagon secretion at low glucose concentrations: evidence for adenosine triphosphate-sensitive potassium channel involvement.

    Muñoz A, Hu M, Hussain K, Bryan J, Aguilar-Bryan L, Rajan AS.

    Endocrinology. 2005 Dec;146(12):5514-21. Epub 2005 Aug 25.PMID: 16123162 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Threshold for glucose-stimulated insulin secretion in pancreatic islets of genetically obese (ob/ob) mice is abnormally low.

    Chen NG, Tassava TM, Romsos DR.

    J Nutr. 1993 Sep;123(9):1567-74.PMID: 8360782 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Interaction of exercise, insulin, and hypoglycemia studied using euglycemic and hypoglycemic insulin clamps.

    Zinker BA, Allison RG, Lacy DB, Wasserman DH.

    Am J Physiol. 1997 Apr;272(4 Pt 1):E530-42.PMID: 9142871 [PubMed - indexed for MEDLINE]Related articles

    14.

    Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.

    Rossetti L, Stenbit AE, Chen W, Hu M, Barzilai N, Katz EB, Charron MJ.

    J Clin Invest. 1997 Oct 1;100(7):1831-9.PMID: 9312184 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia.

    Degn KB, Brock B, Juhl CB, Djurhuus CB, Grubert J, Kim D, Han J, Taylor K, Fineman M, Schmitz O.

    Diabetes. 2004 Sep;53(9):2397-403.PMID: 15331551 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Experimental benefit of moxonidine on glucose metabolism and insulin secretion in the fructose-fed rat.

    Rösen P, Ohly P, Gleichmann H.

    J Hypertens Suppl. 1997 Jan;15(1):S31-8.PMID: 9050983 [PubMed - indexed for MEDLINE]Related articles

    17.

    Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response.

    Banarer S, McGregor VP, Cryer PE.

    Diabetes. 2002 Apr;51(4):958-65.PMID: 11916913 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Insulin secretion to glucose as well as nonglucose stimuli is impaired in spontaneously diabetic Nagoya-Shibata-Yasuda mice.

    Hamada Y, Ikegami H, Ueda H, Kawaguchi Y, Yamato E, Nojima K, Yamada K, Babaya N, Shibata M, Ogihara T.

    Metabolism. 2001 Nov;50(11):1282-5.PMID: 11699045 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers.

    Nauck MA, Heimesaat MM, Behle K, Holst JJ, Nauck MS, Ritzel R, Hüfner M, Schmiegel WH.

    J Clin Endocrinol Metab. 2002 Mar;87(3):1239-46.PMID: 11889194 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The influence of genetic background on the induction of oxidative stress and impaired insulin secretion in mouse islets.

    Zraika S, Aston-Mourney K, Laybutt DR, Kebede M, Dunlop ME, Proietto J, Andrikopoulos S.

    Diabetologia. 2006 Jun;49(6):1254-63. Epub 2006 Mar 29.PMID: 16570159 [PubMed - indexed for MEDLINE]Related articles